The White House budget set for release Monday will include almost $17 billion to fight opioid addiction; a profile of FDA chief Scott Gottlieb, MD, describes him as someone who's become adept at balancing competing interests; the Trump administration is set to appoint a new drug czar with no public health experience.
The White House’s fiscal 2019 budget set to be released Monday will include nearly $17 billion for the opioid epidemic, The Hill reported. HHS will received the bulk of the money to expand prevention, treatment, recovery and mental health services—$3 billion for 2018 and $10 billion for 2019.
Scott Gottlieb, MD, is approaching his FDA job as chief of the agency in a more conventional way than other administration appointees, The New York Times reported this weekend. He is keeping both the president and industry supporters satisfied while also quieting some skeptics, and is trying to balance protecting public health while also offering rewards to industry.
The While House deputy chief of staff, an attorney with no public health experience, is slated to become the next head of the Office of National Drug Control Policy, STAT reported. Jim Carroll would serve as the administration’s next drug czar. In related news, health advocates are waiting to see if the office is still slated to see its budget cut 95% in the administration’s upcoming budget.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen